Posaconazole Tablets 300 mg Suppliers & Bulk Manufacturers
Available Forms: Delayed-Release Tablets
Available Strengths: 300 mg
Reference Brands: Noxafil(US & EU)
Category: Anti-fungal
Posaconazole delayed-release tablets inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis essential for fungal cell membranes. They provide broad-spectrum antifungal activity, improved absorption, and enhanced bioavailability. Benefits include effective prophylaxis and treatment of invasive fungal infections, with convenient dosing, making them vital for managing severe fungal diseases.
Product Description:
Posaconazole delayed-release tablets are approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We facilitate efficient market access for posaconazole delayed-release tablets, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Posaconazole Tablets — third party manufacturing & bulk supply
Posaconazole Tablets 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Posaconazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Posaconazole Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Posaconazole is used to prevent and treat severe fungal infections, especially in patients with weakened immune systems such as those undergoing chemotherapy, stem-cell transplant, or with hematologic malignancies. It is effective against invasive aspergillosis, mucormycosis, and difficult-to-treat Candida infections, and is often chosen when other antifungal therapies are not sufficient or not tolerated.
Posaconazole contains the active triazole antifungal compound posaconazole. It is formulated with pharmaceutical excipients that improve its absorption and ensure consistent systemic exposure for effective antifungal activity.
The primary trade name for posaconazole is Noxafil, widely recognized in the USA, EU, UK, and many other markets.
Noxafil is manufactured by Merck & Co. (MSD). Generic posaconazole is also produced by various GMP-certified pharmaceutical manufacturers around the world.
The generic name is posaconazole.
The main brand name is Noxafil.
Posaconazole is manufactured in Merck’s regulated facilities in the USA and Europe, and also by multiple approved global GMP manufacturers that produce generic posaconazole for international distribution.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View Details
Terconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
